A Level · Topic 19.2
A-Level Biology 9700 / Topic 19 / A2

Making medicines, reading risks, repairing genes.

Genetic technology now makes human proteins in bacteria and cultured cells, tests people for disease alleles before symptoms appear, and inserts working alleles into a patient's cells. Each of these brings benefits, and each raises questions that society has to answer.

The key idea

Gene editing is a form of genetic engineering in which DNA is inserted, deleted or replaced at a specific site in the genome, for example using a guide RNA to lead a nuclease to the target. Recombinant human proteins such as insulin (diabetes), factor VIII (haemophilia) and adenosine deaminase (one form of SCID) are identical to the human proteins, made in large amounts and free from the infection risks of animal or donor sources. Genetic screening tests DNA for particular alleles, such as harmful BRCA1 and BRCA2 alleles (breast cancer), the Huntington's disease allele and cystic fibrosis alleles, so people can make informed decisions and start treatment early. Gene therapy adds a working allele to a patient's cells using a vector, as in treatments for SCID and inherited eye diseases. All of these raise social and ethical questions about consent, privacy, discrimination, cost, safety and the limits of what should be changed.

patient with SCID faulty ADA allele bone marrow stem cells removed viral vector adds normal ADA allele modified cells grown in culture cells returned to patient make working lymphocytes somatic gene therapy: body cells only, not inherited germ-line changes (gametes, embryos) would be inherited
Fig. 1: somatic gene therapy for SCID caused by lack of adenosine deaminase; the patient's own stem cells are given a normal allele outside the body and then returned
Section 01

Gene editing: changes at a chosen site.

Pick deletion, insertion or replacement, then press Edit. The nuclease with its guide RNA moves to the highlighted target (six base pairs), cuts both strands, and the cell repairs the cut. In insertion and replacement the new bases appear in green.

Section 02

Recombinant human proteins.

Choose insulin, factor VIII and ADA in turn. Notice that factor VIII is made in cultured GM hamster cells, not bacteria. The other chips (genetic screening, gene therapy: SCID, gene therapy: eye and ethics) go with the next two sections below.

ProteinTreatsOlder sourceAdvantages of the recombinant protein
insulintype 1 diabetespancreases of pigs and cattleidentical to human insulin, so fewer allergic or immune reactions; made in large quantities by GM bacteria or yeast at lower cost; reliable supply; no risk of animal diseases; avoids ethical and religious objections to using animal products
factor VIIIhaemophilia A (a blood-clotting protein is missing)plasma from donated human bloodno risk of infections such as HIV or hepatitis from donated blood; supply does not depend on donors; made in mammalian cells, which add the sugar groups the protein needs
adenosine deaminase (ADA)ADA deficiency, one cause of severe combined immunodeficiency (SCID)enzyme from cattlehuman enzyme, so less likely to cause an immune response; given by injection to restore some immune function until gene therapy or a bone marrow transplant
Examiner trap

Bacteria cannot add sugar groups or modify proteins the way human cells do, so some recombinant human proteins, such as factor VIII, are made in cultured mammalian cells instead.

Stage 1 · Learn

Check what the sim just showed you

Four quick checks. Each correct answer earns XP and records this skill on your profile.

Quick check+10 XP

In the gene editing simulator, what leads the nuclease to the highlighted target site?

Quick check+10 XP

You choose replacement and press Edit. What happens at the target?

Quick check+10 XP

The medicine simulator shows factor VIII being made by GM hamster cells in culture. Why are mammalian cells used rather than bacteria?

Quick check+10 XP

In the simulator's SCID gene therapy, which cells receive the normal ADA allele?

Section 03

Genetic screening and gene therapy.

In the medicine tab above, the genetic screening chip shows a test strip for BRCA1, BRCA2, HTT (the Huntington's gene) and CFTR (the cystic fibrosis gene). The two gene therapy chips show a viral vector and stem cells for SCID, and an injection under the retina for inherited eye disease.

Section 04

Weighing the ethics.

Use the ethics chip in the medicine tab to see benefits and concerns balanced on a scale. Exam questions ask you to discuss both sides.

BenefitsConcerns
early diagnosis and treatment; informed decisions about health and having childrenanxiety and stress, especially for untreatable conditions such as Huntington's disease
preventive action for people at high risk of cancerwho should be told: relatives share alleles, so a result affects the whole family
treatment of previously incurable diseases by gene therapyprivacy, and possible discrimination by employers or insurance companies
fewer children born with severe genetic diseasesselection or termination of embryos and fetuses; where to draw the line between disease and other traits ("designer babies")
knowledge that drives new therapieshigh cost and unequal access; long-term safety of gene therapy; germ-line changes would affect future generations without their consent, and are banned in humans in most countries
Stage 2 · Exam

Exam-style questions

Unlocks once the four checks above are done. Worth more XP, written to A Level Paper 4 standard.

Finish the four checks above to unlock the exam questions
Exam style+20 XP

Which is an advantage of using recombinant human insulin rather than insulin extracted from pigs?

Exam style+20 XP

Why does screening for Huntington's disease raise more ethical concern than screening newborns for cystic fibrosis?

Exam style+20 XP

A child is treated for SCID by somatic gene therapy. Which statement is correct?

Exam style+20 XP

Which describes gene editing rather than older methods of genetic engineering?

Skill unlocked

Genetic technology in medicine, mastered.

This skill is now recorded on your profile. Keep the chain going.

-Rank -Level -Score -Topics
Go deeper · practice
Six original Cambridge-style questions
Gene editing, recombinant insulin, factor VIII and ADA, genetic screening for BRCA1/2, Huntington's disease and cystic fibrosis, gene therapy for SCID and eye disease, and the ethics.